0
0
By Annonciata BYUKUSENGE
President Paul Kagame said Rwanda was one of the three destinations selected on the African continent as the site for the construction of the COVID-19 vaccine plant and that it had come a long way towards implementing the project.
President Kagame made the remarks on June 21, 2021, during a meeting with the Qatar Economic Forum.
President Kagame has said that for the African continent to be fully vaccinated, it is necessary to start working on it.
“It simply came to our notice then. The International Monetary Fund (IFC), we have the European Union, and we have other partners want to come and join our continent in that. “
He said Rwanda, South Africa, and Senegal were the countries selected in Africa to build COVID-19 vaccination centers.
Full text
“Once this is done, I think we will be able to get the vaccines we need on time and around the world. There will be three COVID-19 vaccination sites on our continent, and these countries have already made great strides in that line which are South Africa, Senegal, and Rwanda. “
President Kagame said the companies would make vaccines using mRNA technology and reaffirmed that Rwanda has come a long way in preparing for the launch of the plant.
“We will be in a place on the Continent where vaccination activities will take place, especially in Rwanda. We have worked with industries that have experience in mRNA technology,” he said.
How it started
“This is a new technology that is being used in many fields, including agriculture and other epidemics. We have already talked to the owners of this technology, and we are talking to people who will provide financial support, and I think in a few months we can start doing something that has never happened before.”
Messenger RNA (mRNA) is a new method used in the treatment of infectious diseases, including COVID-19.
The mRNA method was previously thought to be responsible for Zika vaccines, influenza, etc., but researchers began using it after the discovery of the SARS-CoV-2 virus that causes COVID-19.
It was not until the 1990s that a 66-year-old Hungarian, Katalin Karikó, revealed for the first time that mRNA could be involved in vaccination, but was weeded out.
American vaccines, including Moderna and Pfizer, were made in this way; while the Johnson & Johnson ones, the Indian AstraZeneca, the Russian Sputnik V, and the Chinese Sinovac were made in a way known as the “adenovirus” that uses the virus to treat the virus.
At present, mRNA-based vaccines are still scarce, but they are not as difficult as traditional methods, as they are used only in laboratory equipment.
It is expected that as technology advances, mRNAs will be used to create a single vaccine that will protect against all infectious diseases that can be resisted, vaccinated, and differentiated from the number of doses that will be given to a person.
Verification
WTO head says South Africa, Senegal, Rwanda and Nigeria considered as vaccine production hubs
Conclusion
Rwanda is also building a COVID-19 vaccine plant, and was also announced by Ngozi Okonjo-Iweala, the head of the World Trade Organization (WTO), who said Nigeria could also expand to these three countries.
